Literature DB >> 8045729

Serum iron, total iron binding capacity and ferritin in early Huntington disease patients.

P J Morrison1, N C Nevin.   

Abstract

Serum iron, total iron binding capacity and ferritin was estimated in 42 patients with early Huntington disease (HD) and in 148 matched controls. Ferritin levels were significantly low in affected male subjects as compared to controls. Iron levels and total iron binding capacity were normal in HD patients. The importance of this finding, that occurs early in the pathogenesis of HD, is unknown.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045729     DOI: 10.1007/bf02943258

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  10 in total

1.  A second human ferritin H locus on chromosome 11.

Authors:  P Papadopoulos; D Bhavsar; E Zappone; V David; C Jones; M Worwood; J Drysdale
Journal:  Cytogenet Cell Genet       Date:  1992

2.  Nutritional evaluation of Huntington disease patients.

Authors:  L M Morales; J Estévez; H Suárez; R Villalobos; L Chacín de Bonilla; E Bonilla
Journal:  Am J Clin Nutr       Date:  1989-07       Impact factor: 7.045

3.  Serum ferritin deficiency in Huntington's disease patients.

Authors:  E Bonilla; J Estévez; H Suárez; L M Morales; L Chacin de Bonilla; R Villalobos; J O Dávila
Journal:  Neurosci Lett       Date:  1991-08-05       Impact factor: 3.046

4.  Iron and calcium deposits in the brain; their pathologic significance.

Authors:  G STRASSMANN
Journal:  J Neuropathol Exp Neurol       Date:  1949-10       Impact factor: 3.685

5.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  Trinucleotide repeat repeat repeat.

Authors:  P J Morrison
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

7.  Determination of Cu, Mn, Fe, and Ca in six regions of normal human brain, by atomic absorption spectroscopy.

Authors:  W J Goldberg; N Allen
Journal:  Clin Chem       Date:  1981-04       Impact factor: 8.327

8.  Decreased ferritin levels in brain in Parkinson's disease.

Authors:  D T Dexter; A Carayon; M Vidailhet; M Ruberg; F Agid; Y Agid; A J Lees; F R Wells; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

9.  Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.

Authors:  G J Harris; G D Pearlson; C E Peyser; E H Aylward; J Roberts; P E Barta; G A Chase; S E Folstein
Journal:  Ann Neurol       Date:  1992-01       Impact factor: 10.422

10.  Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission.

Authors:  M C Garrett; P Soares-da-Silva
Journal:  J Neurochem       Date:  1992-01       Impact factor: 5.372

  10 in total
  5 in total

1.  Systems genetic analysis of multivariate response to iron deficiency in mice.

Authors:  Lina Yin; Erica L Unger; Leslie C Jellen; Christopher J Earley; Richard P Allen; Ann Tomaszewicz; James C Fleet; Byron C Jones
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-28       Impact factor: 3.619

Review 2.  Zebrafish an experimental model of Huntington's disease: molecular aspects, therapeutic targets and current challenges.

Authors:  Vishal Kumar; Charan Singh; Arti Singh
Journal:  Mol Biol Rep       Date:  2021-10-19       Impact factor: 2.316

Review 3.  Modeling neurodegeneration in zebrafish.

Authors:  Yanwei Xi; Sandra Noble; Marc Ekker
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

4.  Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review.

Authors:  Rita L Vaz; Tiago F Outeiro; Joaquim J Ferreira
Journal:  Front Neurol       Date:  2018-06-01       Impact factor: 4.003

Review 5.  A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

Authors:  Edina Silajdžić; Maria Björkqvist
Journal:  J Huntingtons Dis       Date:  2018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.